| Literature DB >> 34203418 |
Eun-Soo Lee1, Young-Ki Kim1,2,3.
Abstract
Asbestos-cement slate roofs are one of the most common environmental causes of asbestos exposure. However, few studies have examined residential asbestos-cement slate-related exposure and its effects on human health. This study was performed to evaluate cumulative asbestos exposure levels and to calculate the Excess Lifetime Cancer Risk (ELCR) of residents of asbestos-cement slate-roofed houses. We reviewed previous Korean literature to estimate the concentration of airborne asbestos from asbestos-cement slate roofed buildings. Finally, eight studies were selected, and a pooled analysis was performed. The results derived from the pooled analysis were combined with the data from a health impact survey conducted from 2009 to 2016 at the Environmental Health Center for Asbestos (EHCA) of the Yangsan Pusan National University Hospital, and a carcinogenic risk assessment was performed. As a result, the representative value of the indoor exposure concentration related to asbestos-cement slate was found to be 0.0032 f/cc on average, and the representative value of the exposure related to occupational asbestos-cement slate dismantling and demolition was found to be 0.0034 f/cc. In addition, the ELCR of asbestos-cement slate related indoor exposure and occupational dismantling and demolition was found to be of medium risk, and the ELCR of residential dismantling and demolition of asbestos-cement slate was less than 10-6, indicating that the risk was low. Since there is no threshold for carcinogenicity related to asbestos, this should not be ignored even if the risk appears low, and it would be reasonable to calculate the carcinogenic risk based on total lifetime exposure. More studies on asbestos exposure scenarios and the scope of similar exposure groups through additional data collection and further analysis of risk are needed.Entities:
Keywords: asbestos; cancer; exposure; risk
Mesh:
Substances:
Year: 2021 PMID: 34203418 PMCID: PMC8297172 DOI: 10.3390/ijerph18136925
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Asbestos-cement slate roofs (left) and Scanning Electron Microscope (SEM) image (right) of chrysotile in the slate roofs. The bar size in the right image indicates 100 μm.
Figure 2Flow of the Selection Process of Studies for Review.
Characteristics of Korean studies included in this review where the asbestos concentration was presented as f/cc.
| Study | Study Year (s) | Number of Samples | GM (±GSD) * | AM (±ASD) ** | Min | Max | Analytic Method | Building Construction Year or Type of Exposure |
|---|---|---|---|---|---|---|---|---|
| Kim et al. [ | 2008 | 9 | 0.0030 (±1.3960) | - | 0.0020 | 0.0060 | PCM *** | 1960s |
| 2 | 0.0010 (±1.0000) | - | 0.0010 | 0.0010 | PCM *** | 1970s | ||
| 8 | 0.0290 (±7.4040) | - | 0.0040 | 0.2310 | PCM *** | 1980s | ||
| 8 | 0.0050 (±1.4690) | - | 0.0030 | 0.0100 | PCM *** | 1990s | ||
| Jang et al. [ | 2013 | 18 | 0.0001 (±0.04879) | 0.0019 (±0.0027) | N.D. | 0.0085 | PCM *** | <1979 |
| 24 | 0.00006 (±0.04704) | 0.0012 (±0.0015) | N.D. | 0.0066 | 1980–1985 | |||
| 18 | 0.0003 (±0.04025) | 0.0025 (±0.0026) | N.D. | 0.0082 | ≥1986 | |||
| Kim et al. [ | 2016 | 36 | 0.0024 | 0.0026 (±0.0011) | 0.0008 | 0.0051 | PCM *** | ≤1980 |
| 36 | 0.0027 | 0.0030 (±0.0013) | 0.0012 | 0.0058 | ≥1981 | |||
| Heo et al. [ | 2017 | 30 | 0.0027 (±0.0007) | - | 0.0012 | 0.0040 | PCM *** | ≤1969 |
| 30 | 0.0022 (±0.0007) | - | 0.0082 | 0.0037 | ≤1970 | |||
| 30 | 0.0024 (±0.0007) | - | 0.0008 | 0.0039 | Indoor | |||
| 30 | 0.0025 (±0.0008) | - | 0.0012 | 0.0040 | outdoor | |||
| Jeong et al. [ | 2013 | 6 | 0.0022 (±0.00057) | - | 0.0016 | 0.0031 | PCM *** | Indoor |
| 6 | 0.0016 (±0.00065) | - | 0.0008 | 0.0027 | outdoor | |||
| Choi et al. [ | 2001 | 23 | 0.047 (±1.658) | - | 0.018 | 0.117 | PCM *** | Roof removal |
| Kim et al. [ | 2009 | 24 | 0.002 (±1.956) | - | 0.001 | 0.010 | PCM *** | Slate roof |
| Cho et al. [ | 2013 | 253 | 0.002 (±0.004) | - | 0.001 | 1.143 | PCM *** | During the process |
| 316 | 0.001 (±0.001) | - | 0.001 | 0.009 | After the process |
* Geometric mean (±Geometric standard deviation); ** Arithmetic mean (±Arithmetic standard deviation); *** Phase-contrast microscopy.
Asbestos exposure level by each asbestos-cement slate exposure scenario according to the pooled analysis.
| Exposure Scenario | Number of Samples | Arithmetic Mean (f/cc) | Arithmetic Standard Deviation | Min | Max |
|---|---|---|---|---|---|
| Construction Year | |||||
| ≤1980 | 95 | 0.0025 | 2.27 × 10−7 | Not detected | 0.0085 |
| >1980 | 94 | 0.0207 | 4.40 × 10−3 | Not detected | 0.0231 |
| (Except outlier) | 86 | 0.0026 | 1.59 × 10−6 | Not detected | 0.0100 |
| Indoor or Outdoor | |||||
| Indoor | 10 | 0.0032 | 1.73 × 10−6 | 0.0006 | 0.0067 |
| Outdoor | 10 | 0.0015 | 2.70 × 10−8 | 0.0002 | 0.0027 |
| Occupational asbestos-cement slate roof repair or dismantling | 616 | 0.0034 | 6.62 × 10−7 | 0.0010 | 1.1430 |
| Residential asbestos-cement slate roof repair or dismantling (estimated) | - | 1.83 × 10−5 | - | - | - |
The characteristics of the asbestos-cement slate-exposed group.
| Variable | Number of Subjects | % | |
|---|---|---|---|
| No exposure to asbestos other than asbestos-cement slate | 575 | 46.8 | |
| Type of asbestos-cement slate exposure | Slate roof only | 929 | 75.65 |
| Slate roof or slate concentrated area | 299 | 24.35 | |
| Exposure period to asbestos-cement slate (years) | ≤4 | 138 | 11.24 |
| 5~9 | 148 | 12.05 | |
| 10~19 | 201 | 16.37 | |
| ≥20 | 741 | 60.34 | |
| Experience in asbestos-cement slate repair | Absent | 866 | 70.52 |
| Present | 362 | 29.48 | |
| Asbestos-cement slate repair period (years) | None | 902 | 73.45 |
| ≤4 | 200 | 16.29 | |
| 5~9 | 55 | 1.77 | |
| 10~19 | 26 | 0.84 | |
| ≥20 | 45 | 1.45 | |
| Total | 1228 | 100.00 | |
Cumulative exposure level to asbestos by each asbestos-cement slate exposure scenario.
| Indoor Exposure | Number of Subjects (%) | AM * (f/cc) | ASD ** | 95% CI *** | ||
|---|---|---|---|---|---|---|
| Asbestos cumulative exposure level | 575 (100) | 0.044 | 0.014 | 0.043 | 0.045 | |
| Age | ≤29 | 2 (0.35) | 0.017 | 0.019 | −0.152 | 0.186 |
| 30~39 | 14 (2.43) | 0.024 | 0.018 | 0.013 | 0.034 | |
| 40~49 | 34 (5.91) | 0.037 | 0.016 | 0.031 | 0.043 | |
| 50~59 | 103 (17.91) | 0.039 | 0.016 | 0.036 | 0.042 | |
| 60~69 | 141 (24.52) | 0.045 | 0.014 | 0.042 | 0.047 | |
| ≥70 | 281 (48.87) | 0.047 | 0.011 | 0.046 | 0.048 | |
| Sex | Male | 215 (37.39) | 0.044 | 0.014 | 0.042 | 0.046 |
| Female | 360 (62.61) | 0.044 | 0.014 | 0.042 | 0.045 | |
|
|
|
|
|
| ||
| Asbestos cumulative exposure level | 575 (100) | 0.047 | 0.015 | 0.045 | 0.048 | |
| Age | ≤29 | 2 (0.35) | 0.018 | 0.020 | −0.161 | 0.198 |
| 30~39 | 14 (2.43) | 0.025 | 0.019 | 0.014 | 0.036 | |
| 40~49 | 34 (5.91) | 0.039 | 0.017 | 0.033 | 0.045 | |
| 50~59 | 103 (17.91) | 0.042 | 0.016 | 0.038 | 0.045 | |
| 60~69 | 141 (24.52) | 0.048 | 0.015 | 0.045 | 0.050 | |
| ≥70 | 281 (48.87) | 0.050 | 0.012 | 0.049 | 0.052 | |
| Sex | Male | 215 (37.39) | 0.047 | 0.015 | 0.045 | 0.049 |
| Female | 360 (62.61) | 0.047 | 0.015 | 0.045 | 0.048 | |
|
|
|
|
|
| ||
| Asbestos cumulative exposure level | 575 (100) | 0.000251 | 7.97 × 10−5 | 0.000245 | 0.000258 | |
| Age | ≤29 | 2 (0.35) | 9.95 × 10−5 | 0.000108 | −0.000870 | 0.001067 |
| 30~39 | 14 (2.43) | 0.000135 | 0.000100 | 7.67 × 10−5 | 0.000193 | |
| 40~49 | 34 (5.91) | 0.000212 | 9.26 × 10−5 | 0.000180 | 0.000245 | |
| 50~59 | 103 (17.91) | 0.000224 | 8.88 × 10−5 | 0.000206 | 0.000241 | |
| 60~69 | 141 (24.52) | 0.000256 | 7.85 × 10−5 | 0.000243 | 0.000269 | |
| ≥70 | 281 (48.87) | 0.00027 | 6.24 × 10−5 | 0.000263 | 0.000277 | |
| Sex | Male | 215 (37.39) | 0.000251 | 8.04 × 10−5 | 0.000240 | 0.000262 |
| Female | 360 (62.61) | 0.000251 | 7.94 × 10−5 | 0.000243 | 0.000259 | |
* Arithmetic mean; ** Arithmetic standard deviation; *** Confidence interval.
ELCR by each asbestos-cement slate exposure scenario.
| Indoor Exposure | Number of Subjects (%) | AM ** (f/cc) | ASD *** | 95% CI **** | ||
|---|---|---|---|---|---|---|
| ELCR * | 575 (100) | 4.81 × 10−5 | 3.53 × 10−5 | 4.52 × 10−5 | 5.10 × 10−5 | |
| Age | ≤29 | 2 (0.35) | 8.70 × 10−5 | 9.84 × 10−5 | −0.0008 | 0.000971 |
| 30~39 | 14 (2.43) | 9.51 × 10−5 | 7.84 × 10−5 | 4.98 × 10−5 | 0.00014 | |
| 40~49 | 34 (5.91) | 9.68 × 10−5 | 4.86 × 10−5 | 7.99 × 10−5 | 0.000114 | |
| 50~59 | 103 (17.91) | 8.20 × 10−5 | 3.85 × 10−5 | 7.45 × 10−5 | 8.95 × 10−5 | |
| 60~69 | 141 (24.52) | 4.77 × 10−5 | 1.55 × 10−5 | 4.52 × 10−5 | 5.03 × 10−5 | |
| ≥70 | 281 (48.87) | 2.73 × 10−5 | 5.2 × 10−5 | 2.67 × 10−5 | 2.79 × 10−5 | |
| Sex | Male | 215 (37.39) | 5.27 × 10−5 | 4.07 × 10−5 | 4.72 × 10−5 | 5.81 × 10−5 |
| Female | 360 (62.61) | 4.53 × 10−5 | 3.14 × 10−5 | 4.21 × 10−5 | 4.86 × 10−5 | |
|
|
|
|
|
| ||
| ELCR | 575 (100) | 5.11 × 10−5 | 3.75 × 10−5 | 4.80 × 10−5 | 5.41 × 10−5 | |
| Age | ≤29 | 2 (0.35) | 9.24 × 10−5 | 0.0001 | −0.0008 | 0.0010 |
| 30~39 | 14 (2.43) | 0.0001 | 8.33 × 10−5 | 5.29 × 10−5 | 0.0001 | |
| 40~49 | 34 (5.91) | 0.0001 | 5.17 × 10−5 | 8.48 × 10−5 | 0.0001 | |
| 50~59 | 103 (17.91) | 8.71 × 10−5 | 4.09 × 10−5 | 7.91 × 10−5 | 9.51 × 10−5 | |
| 60~69 | 141 (24.52) | 5.07 × 10−5 | 1.65 × 10−5 | 4.80 × 10−5 | 5.35 × 10−5 | |
| ≥70 | 281 (48.87) | 2.90 × 10−5 | 5.49 × 10−5 | 2.83 × 10−5 | 2.96 × 10−5 | |
| Sex | Male | 215 (37.39) | 5.60 × 10−5 | 4.33 × 10−5 | 5.01 × 10−5 | 6.18 × 10−5 |
| Female | 360 (62.61) | 4.81 × 10−5 | 3.33 × 10−5 | 4.47 × 10−5 | 5.16 × 10−5 | |
|
|
|
|
|
| ||
| ELCR * | 575 (100) | 2.75 × 10−7 | 2.02 × 10−7 | 2.58 × 10−7 | 2.92 × 10−7 | |
| Age | ≤29 | 2 (0.35) | 4.98 × 10−7 | 5.63 × 10−7 | −4.56 × 10−6 | 5.56 × 10−6 |
| 30~39 | 14 (2.43) | 5.44 × 10−7 | 4.48 × 10−7 | 2.85 × 10−7 | 8.03 × 10−7 | |
| 40~49 | 34 (5.91) | 5.54 × 10−7 | 2.78 × 10−7 | 4.57 × 10−7 | 6.51 × 10−7 | |
| 50~59 | 103 (17.91) | 4.69 × 10−7 | 2.20 × 10−7 | 4.26 × 10−7 | 5.12 × 10−7 | |
| 60~69 | 141 (24.52) | 2.73 × 10−7 | 8.88 × 10−8 | 2.58 × 10−7 | 2.88 × 10−7 | |
| ≥70 | 281 (48.87) | 1.56 × 10−7 | 2.96 × 10−8 | 1.52 × 10−7 | 1.59 × 10−7 | |
| Sex | Male | 215 (37.39) | 3.01 × 10−7 | 2.33 × 10−7 | 2.70 × 10−7 | 3.33 × 10−7 |
| Female | 360 (62.61) | 2.59 × 10−7 | 1.79 × 10−7 | 2.41 × 10−7 | 2.78 × 10−7 | |
* Excess Lifetime Cancer Risk; ** Arithmetic mean; *** Arithmetic standard deviation; **** Confidence Interval.
ELCR in indoor slate exposure.
| ELCR * | Number of Subjects (%) | Risk Evaluation |
|---|---|---|
| <10 × 10−6 | 27 (4.70) | Low |
| 10 × 10−6 to 10 × 10−5 | 513 (89.22) | Moderate |
| 10 × 10−5 to 10 × 10−4 | 35 (6.09) | High |
* Excess Lifetime Cancer Risk.